Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Sees Significant Decline in Short Interest

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) was the target of a significant decline in short interest in June. As of June 30th, there was short interest totaling 65,513 shares, a decline of 54.0% from the June 15th total of 142,536 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 1,245,678 shares, the short-interest ratio is presently 0.1 days.

Coloplast A/S Price Performance

Coloplast A/S stock opened at $6.20 on Tuesday. The company has a market cap of $13.97 billion, a P/E ratio of 44.29, a price-to-earnings-growth ratio of 1.94 and a beta of 0.22. Coloplast A/S has a one year low of $5.64 and a one year high of $10.03. The business has a fifty day moving average of $6.08 and a two-hundred day moving average of $7.05. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.09 and a current ratio of 1.75.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The business had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.11 billion. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%. As a group, analysts predict that Coloplast A/S will post 0.38 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on CLPBY shares. The Goldman Sachs Group lowered shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Coloplast A/S currently has a consensus rating of “Hold”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.